Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-10-14
1985-11-05
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 7, 514 15, 514 16, 514 17, 2601125R, A61K 3700, C07C10352
Patent
active
045514453
ABSTRACT:
Compounds acting as antagonists of the an
REFERENCES:
patent: 3371080 (1968-02-01), Boissonnas et al.
patent: 3415805 (1968-12-01), Siedel et al.
patent: 3418307 (1968-12-01), Boissonnas et al.
patent: 3454549 (1969-07-01), Boissonnas et al.
patent: 3497491 (1970-02-01), Zaoral et al.
patent: 3691147 (1972-09-01), Manning
patent: 3700652 (1972-10-01), Manning
patent: 3752799 (1973-08-01), Jost
patent: 3816385 (1974-06-01), Gillessen et al.
patent: 3883498 (1975-05-01), Gillessen et al.
patent: 3980631 (1976-09-01), Prochazka et al.
patent: 4081533 (1978-03-01), Cheesman
patent: 4148787 (1979-04-01), Mulder
patent: 4237119 (1980-12-01), Cort et al.
patent: 4285858 (1981-08-01), Cort et al.
patent: 4367225 (1983-01-01), Manning et al.
patent: 4399125 (1983-08-01), Manning et al.
Dyckes et al., 17 J. Med. Chem. 250 (1974).
Manning et al., 20 J. Med. Chem. 1228 (1977).
Bankowski et al., 21 J. Med. Chem. 850 (1978).
Kruszynski et al., 23 J. Med. Chem. 364 (1980).
Lowbridge et al., 21 J. Med. Chem. 313 (1978).
Chan et al., 161 Science 280 (1968).
Chan et al., 174 J. Pharmacol. Exp. Ther. 541 (1970).
Chan et al., 196 J. Pharmacol. Exp. Ther. 746 (1976).
Nestor et al., 18 J. Med. Chem. 1022 (1975).
Larsson et al., 21 J. Med. Chem. 352 (1978).
Sawyer et al., 212 Science 49 (1981).
Manning et al., 24 J. Med. Chem. 701 (1981).
Merrifield, 85 J. Am. Chem. Soc. 2149 (1963).
Merrifield, 3 Biochemistry 1385 (1964).
Manning, 90 J. Am. Chem. Soc. 1348 (1968).
Manning et al., 19 J. Med. Chem. 376 (1976).
Lowbridge et al., 20 J. Med. Chem. 1173 (1977).
Manning et al., 16 J. Med. Chem. 975 (1973).
Felix et al., 10 J. Peptide Protein Res. 299 (1977).
Botos et al., 22 J. Med. Chem. 926 (1979).
Hope et al., 237 J. Biol. Chem. 1563 (1962).
Schultz et al., 9 J. Med. Chem. 647 (1966).
Nestor et al., 18 J. Med. Chem. 284 (1975).
Huguenin et al., 39 Helv. Chem. Acta, 695 (1966).
Manning et al., 19 J. Med. Chem. 842 (1976).
Law et al., 82 J. Am. Chem. Soc. 4579 (1960).
Manning et al., Peptides, Structure, Function, Dan H. Rich and E. Gross, eds., Pierce Chemical Co., 257 (1981).
Manning et al., 25 J. Med. Chem. 45 (1982).
Butlen et al., 14 Mol. Pharmacol. 1006 (1978).
Sawyer et al., 5 Endocrinology 140 (1974).
D. B. Case et al., 21 Progress in Cardiovascular Diseases 195 (1978).
Bartter et al., 42 Am. J. Med. 790 (1967).
Gisin, 56 Helv. Chem. Acta. 1476 (1973).
Spackman et al., 30 Anal. Chem. 1190 (1958).
Konig et al., 103 Chem. Ber. 788 (1970).
Manning, 90 J. Am. Chem. Soc. 1348 (1968).
du Vigneaud, 76 J. Am. Chem. Soc. 3115 (1954).
Hope et al., 237 J. Biol. Chem. 1563 (1962).
Manning et al., 38 J. Chromatog. 396 (1968).
Moore, 238 J. Biol. Chem. 235 (1963).
Bodanszky et al., 81 J. Am. Chem. Soc. 5688 (1959).
Bodanszky et al., 39 J. Org. Chem. 444 (1974).
Dyckes et al., 17 J. Med. Chem. 969 (1974).
Schild et al., 2 Br. J. Pharmacol. 189 (1947).
Sawyer et al., 63 Endocrinology 694 (1958).
Manning et al., 227 Nature No. 5259, 715 (1970).
Baxter et al., 8 Biochemistry 3592 (1962).
Manning et al., 9 Biochemistry 3925 (1970).
Manning et al., 21 J. Med. Chem. 179 (1978).
Lowbridge et al., 22 J. Med. Chem. 565 (1979).
Manning et al., 36 Federation Proceedings No. 6 (1977).
Manning Maurice
Sawyer Wilbur H.
Phillips Delbert R.
The Medical College of Ohio
The Trustees of Columbia University
LandOfFree
Derivatives of arginine vasopressin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of arginine vasopressin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of arginine vasopressin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-296019